University Hospital, Akershus
Organisation
Trials
The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease
No phase, Recruiting, 2026, 60 people, 25 Sept 2026, clinicaltrials.gov
Collaborator, Phase 2, Recruiting, 2024, 300 people, 3 Jul 2024, clinicaltrials.gov
Collaborator, Phase 2, Recruiting, 2024, 450 people, 8 Feb 2024, clinicaltrials.gov
Phase 2, Recruiting, 2023, 60 people, 16 Feb 2023, clinicaltrials.gov
Phase 2, Completed, 2023, 310 people, 27 Jan 2023, clinicaltrials.gov
Phase 2, Active, not recruiting, 2019, 13 people, 4 May 2021, clinicaltrials.gov
Collaborator, Phase 1/2, Active, not recruiting, 2021, 18 people, 11 Feb 2021, clinicaltrials.gov
Collaborator, Phase 2, Status unknown, 2021, 64 people, 10 Dec 2020, clinicaltrials.gov
Collaborator, Phase 2/3, Recruiting, 2020, 176 people, 14 Aug 2020, clinicaltrials.gov
A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease
Collaborator, Phase 3, Completed, 2020, 410 people, 26 Jun 2018, clinicaltrials.gov
Phase 4, Completed, 2016, 300 people, 20 Oct 2015, clinicaltrials.gov
Phase 2, Withdrawn, 2009, 0 people, 4 Aug 2009, clinicaltrials.gov
Phase 2, Completed, 2010, 99 people, 29 Jun 2009, clinicaltrials.gov
Phase 4, Completed, 2006, 10 people, 9 Jan 2006, clinicaltrials.gov